Selenium for preventing cancer
More than half a dozen Cochrane Reviews have been done in various areas of health, to examine the evidence on the potential benefits of Selenium, a naturally occurring element with both nutritional and toxicological properties. The review looking at its possible role in the prevention of cancer was updated in January 2018 and one of the authors, Maree Brinkman from the Nutrition Biomed Research Institute in Melbourne in Australia. gives us the latest findings in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - May 25, 2018 Category: General Medicine Authors: Cochrane Source Type: podcasts

Primary and secondary resistance in AML
Eytan Stein, MD, from the Memorial Sloan Kettering Cancer Center, New York, NY, discusses the mechanisms of resistance to targeted therapies such as enasidenib and ivosidenib in acute myeloid leukemia... Author: VJOncology Added: 05/25/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 25, 2018 Category: Cancer & Oncology Source Type: podcasts

Targeting IDH mutations for the treatment of AML
Eytan Stein, MD, from the Memorial Sloan Kettering Cancer Center, New York, NY, explains the mechanisms of isocitrate dehydrogenase (IDH) mutations and their effect on myeloid differentiation, ultima... Author: VJOncology Added: 05/25/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 25, 2018 Category: Cancer & Oncology Source Type: podcasts

Big Shoes to Fill as President of AACR Association is over 110 years old
Elaine R. Mardis, PhD, The Institute for Genomic Medicine, talks about Big Shoes to Fill as President of AACR Association is over 110 years old at AACR 2018 Author: Cancer-News Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

KLLN & SEC23B - Novel Predisposition Genes Prediction tools for cancer and autism
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains KLLN & SEC23B Novel Predisposition Genes Prediction tools for cancer and autism at AACR 2018. Author: Cancer-News Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia at AACR 2018. Author: Cancer-News Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

SEC23B is Very Rarely Studied in Cancer Enters the nucleus and plays other roles
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains SEC23B is Very Rarely Studied in Cancer Enters the nucleus and plays other roles at AACR 2018. Author: Cancer-News Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

KLLN is Right Next to PTEN Gene Might play a role in DNA damage response
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains KLLN is Right Next to PTEN Gene Might play a role in DNA damage response at AACR 2018. Author: Cancer-News Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

3D Modeling of PTEN Tumor Suppressor
Charis Eng, MD, PhD, Genomic Medicine Institute - Cleveland Clinic, explains 3D Modeling of PTEN Tumor Suppressor at AACR 2018. Author: Cancer-News Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

What Is a Mediastinoscopy_ [720p]
Dr. David Harpole, Duke University Medical Center, describes the mediastinoscopy and its use in lung cancer staging. Author: cancergrace Added: 05/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 24, 2018 Category: Cancer & Oncology Source Type: podcasts

My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung Cancer, & amp; Mesothelioma (BMIC-037)
Dr. Jack West reviews his top 5 abstracts in stage I-III non-small cell lung cancer, small cell lung cancer, and mesothelioma at ASCO 2018, explaining why each is poised to change the landscape of pat... Author: BeaconMedIC Added: 05/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2018 Category: Cancer & Oncology Source Type: podcasts

PCI in 2018, Colon Cancer Surveillance and Recurrence, LAA Occlusion and Stroke, Vitamin D for Wheezing in Premature Infants, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the May 22, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - May 22, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Zoledronate or Denosumab for Lung Cancer with Bone Metastases [720p]
Dr. Benjamin Levy, Mount Sinai Health Systems, compares zoledronic acid and denosumab, two agents used for treatment of bone metastases in lung cancer. Author: cancergrace Added: 05/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 20, 2018 Category: Cancer & Oncology Source Type: podcasts

Upcoming results from clinical trials for treating relapsed, low grade lymphoma
Nathan Fowler, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, talks about the clinical trials with results being released soon for the treatment of low grade lymphoma. Trials... Author: VJHemOnc Added: 05/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Safety Lead-In from the Beacon Study 48% Overall Response Rate
Scott Kopetz, M.D., Ph.D., FACP, discusses Safety Lead-In from the Beacon Study 48% Overall Response Rate Author: Cancer-News Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Less Predictable Alternate BRAF Mutations Not all BRAF mutations are the same
Scott Kopetz, M.D., Ph.D., FACP, explains Less Predictable Alternate BRAF Mutations Not all BRAF mutations are the same. Author: Cancer-News Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Get Patients into Clinical Trial Sooner than Later Start with aggressive cytotoxic backbone
Scott Kopetz, M.D., Ph.D., FACP, discusses Getting Patients into Clinical Trial Sooner than Later Start with aggressive cytotoxic backbone Author: Cancer-News Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Rare Clones of KRAS Mutant Cells Able to identify resistant clones
Scott Kopetz, M.D., Ph.D., FACP, explains the Rare Clones of KRAS Mutant Cells Able to identify resistant clones Author: Cancer-News Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

BRAF V600E Mutation BRAF with EGFR Provided Synergy
Scott Kopetz, M.D., Ph.D., FACP, explains BRAF V600E Mutation BRAF with EGFR Provided Synergy. Author: Cancer-News Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Hyperprogressive disease in lung cancer
Hyperprogressive disease is a new phenomenon observed in patients treated with anti-PD-1/PD-L1 immunotherapy, characterized by accelerated tumor growth. Interestingly, hyperprogressive disease can occ... Author: VJHemOnc Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Key findings of the ALEX study: Improved therapeutic options for ALK-positive NSCLC
The key findings of the anaplastic lymphoma kinase-positive non-small cell lung cancer (ALEX) study (NCT02075840) has established alectinib as a key treatment compared with crizotinib. In this talk, S... Author: VJHemOnc Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

People Helping People: Scott Hamilton on the Cancer Care Team
Scott Hamilton discusses the importance of the health care industry and everyone on the cancer care team. Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

What is 340B?
COA Cancer Policy Minute with Ted OkonThis Cancer Policy Minute video is part of Community Oncology TV. Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Pharmacy Benefit Managers (PBMs): Abusive Middlemen
COA Cancer Policy Minute with Ted Okon Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

What is Community Oncology?
Did you know that the majority of Americans battling cancer receive their care in what is known as a community oncology practice? Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

The Price of Prescription Drugs: More Complicated Than You Think
COA Cancer Policy Minute with Ted Okon.This Cancer Policy Minute is part of the Community Oncology TV series. Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Spotlight on Cancer Care: Always Looking Forward
Community oncology practice New England Cancer Specialists (NECS) is always looking forward, providing high quality, data-driven, low cost cancer care. Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Spotlight on Cancer Care: Going the Extra Mile for Patients
Community oncology practices like Augusta Oncology take care of the whole patient, from diagnosis and treatment to social and financial issues. Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Celebrity Mark Herzlich & Ted Okon On Fighting Cancer
NFL linebacker and Super Bowl champion Mark Herzlich of the New York Giants sat down with with COA executive director Ted Okon. Here he talks about his cancer journey and advice for others fighting ca... Author: coa Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts

Platinum-Based Chemo Doublets_ Backbone for NSCLC Treatment [720p]
Dr. Jack West, Swedish Cancer Institute, identifies the platinum-based chemotherapy doublet as the backbone of first-line treatment for the majority of NSCLC patients. Author: cancergrace Added: 05/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 16, 2018 Category: Cancer & Oncology Source Type: podcasts

What is the Role of Bevacizumab in Stage IV NSCLC_ [720p]
Dr. Jack West, Swedish Cancer Institute, discusses the anti-angiogenic agent bevacizumab (Avastin) and the trial evidence of its efficacy for non-squamous NSCLC. Author: cancergrace Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 16, 2018 Category: Cancer & Oncology Source Type: podcasts

Histology-Specific Regimens - Squamous [720p]
Dr. Jack West, Swedish Cancer Institute, reviews the choices for a first-line chemotherapy regimen based on a squamous histology Author: cancergrace Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Histology-Specific Recommendations - Large-Cell Neuroendocrine [720p]
Dr. Jack West, Swedish Cancer Institute, identifies the best choice for first-line chemotherapy for large-cell neuroendocrine histology. Author: cancergrace Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Lurbinectedin Focus - Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on new data co... Author: Cancer-Roundtables Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy - Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on immunothera... Author: Cancer-Roundtables Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Small Cell Lung Cancer Virtual Roundtable - ROVA-T
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads this section on ROVA-T of a... Author: Cancer-Roundtables Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Small Cell Lung Cancer Virtual Roundtable
H. Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Founder & President, Grace Global Resource for Advancing Cancer Education leads a roundtable discussing newly r... Author: Cancer-Roundtables Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Are There Clinically Significant Distinctions Between PD-1 and PD-L1_ [720p]
Dr. Jack West, Swedish Cancer Institute, compares the mechanism of action, efficacy and toxicity of PD-1 and PD-L1 inhibitors. Author: cancergrace Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts

Rociletinib_Osimertinib for EGFR T790M-negative NSCLC [720p]
Dr. Jack West, Swedish Cancer Institute, reviews trial evidence for the efficacy of rociletinib and osimertinib for EGFR acquired resistance not driven by a T790M mutation. Author: cancergrace Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts

Maintenance Therapy for Advanced NSCLC [720p]
Dr. Jack West, Swedish Cancer Institute, defines maintenance therapy in advanced NSCLC and discusses maintenance treatment strategies. Author: cancergrace Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts

Bronchoscopy and EBUS [720p]
Dr. Jed Gorden, Swedish Cancer Institute, describes the differences between bronchoscopy and endobronchial ultrasound, highlighting the advantages of EBUS in diagnosis and staging Author: cancergrace Added: 05/14/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 14, 2018 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Screening - Process and Potential Benefits [720p]
Dr. Jed Gorden, Swedish Cancer Institute, reviews the lung cancer screening process, including low-dose CT scanning, smoking cessation, follow-up testing and counseling, and describes the potential be... Author: cancergrace Added: 05/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy as First-Line Treatment [720p]
Dr. Jack West, Swedish Cancer Institute, raises the question of whether to use immune checkpoint inhibitors as first-line treatment of lung cancer, alone or in combination with chemotherapy. Author: cancergrace Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy Combinations [720p]
Dr. Jack West, Swedish Cancer Institute, discusses current trials seeking to determine the efficacy of combining immunotherapy agents in lung cancer Author: cancergrace Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Rova-T Shows Promise in Small Cell Lung Cancer [720p]
1st Video in the GRACE ASCO 2016 Lung Cancer Roundtable series, featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD. Dr. West moderates this roundtable discussio... Author: cancergrace Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts

Can Online Patient Groups Speed New Targeted Therapies_ [720p]
2nd video in GRACE ASCO 2016 Lung Cancer Roundtable series, featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD. Dr. West moderates the subject of if online grou... Author: cancergrace Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 12, 2018 Category: Cancer & Oncology Source Type: podcasts

The role of Cure Leukemia in improving access to clinical trials for patients
Cure Leukemia is a leading center for the development of new drug and transplant treatments for patients with hematological cancers. Its aim is to improve the access to the latest clinical trials for ... Author: VJHemOnc Added: 05/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Local Consolidation Therapies for Oligometastases [720p]
4th video in GRACE ASCO 2016 Lung Cancer Roundtable series, featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD. Dr. West moderates the discussion featuring loca... Author: cancergrace Added: 05/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 11, 2018 Category: Cancer & Oncology Source Type: podcasts

JAMA Oncology : Outcomes of Multiple-Gene Sequencing After Diagnosis of Breast Cancer
Interview with Allison W. Kurian, M.D., M.Sc., author of Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 10, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

Basics of Small Cell Lung Cancer [720p]
Dr. Rachel Sanborn, Providence Thoracic Oncology Program, discusses the topic of lung cancer and that there is an entire spectrum of different kinds of cancers that have started inside the lungs. Smal... Author: cancergrace Added: 05/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 9, 2018 Category: Cancer & Oncology Source Type: podcasts